Home › Grants › CDC-RFA-JG-26-0142
ForecastedEnding HIV and TB as public health threats through an accelerated and sustained comprehensive response in India
Federal funding opportunity CDC-RFA-JG-26-0142 from Centers for Disease Control-GHC.
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- October 1, 2025
- Closes
- See announcement
- Expected awards
- 2
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.067, 93.494
- Category
- Health
- Archives
- July 12, 2026
Program funding history
Awards made under Assistance Listing 93.067 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $1.7B
- FY2025 obligated
- $876.1M
- FY2026 (to date) obligated
- $506.8M
- Awards in window
- 438
Top recipients: The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric Aids Foundation, Management and Development for Health, Wits Health Consortium (pty) Ltd, Center for International Health, Education and Biosecurity - Kenya
Source: USAspending.gov · refreshed July 2026
Synopsis
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $6,000,000 for Year 1, subject to the availability of funds.
This NOFO supports India’s National AIDS Control Organization (NACO), Central Tuberculosis Division (CTD), and other departments in the Ministry of Health and Family Welfare (MoHFW). The goal is to enhance systems that accelerate and sustain epidemic control, in line with the National AIDS Control Program (NACP)-VI and the National TB Elimination Program (NTEP), while working to eradicate HIV and TB as public health threats.
The NOFO aims to transition essential services to local ownership and foster cooperation with interest holders at all levels. To accomplish this goal you should incorporate innovative and evidence-based strategies to:
• Prevent new infections.
• Facilitate early case detection.
• Ensure seamless linkage to care.
• Promote treatment adherence.
• Achieve viral suppression.
Key activities include:
• Closing gaps in HIV and TB testing and treatment.
• Delivering integrated services for HIV and co-morbidities.
• Strengthening program cooperation and ownership to enhance national efforts.
• Improving prevention, detection, and response to infectious diseases.
Advancing innovative HIV and TB service delivery under local leadership will create a sustainable framework for epidemic control that aligns with U.S. global health priorities, ultimately saving lives and bolstering global health security.
Who can apply
- Native American tribal governments (Federally recognized)
- State governments
- Public housing authorities/Indian housing authorities
- For profit organizations other than small businesses
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- County governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Never miss a funding deadline again
Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.
Get funding alerts